D'Alessio G - Search Results

1

Biological properties of a human compact anti-ErbB2 antibody.

De Lorenzo C, Cozzolino R, Carpentieri A, Pucci P, Laccetti P, D'Alessio G. De Lorenzo C, et al. Carcinogenesis. 2005 Nov;26(11):1890-5. doi: 10.1093/carcin/bgi146. Epub 2005 Jun 1. Carcinogenesis. 2005. PMID: 15930029

2

A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas.

De Lorenzo C, Arciello A, Cozzolino R, Palmer DB, Laccetti P, Piccoli R, D'Alessio G. De Lorenzo C, et al. Cancer Res. 2004 Jul 15;64(14):4870-4. doi: 10.1158/0008-5472.CAN-03-3717. Cancer Res. 2004. PMID: 15256457

3

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

De Lorenzo C, D'Alessio G. De Lorenzo C, et al. FEBS J. 2009 Mar;276(6):1527-35. doi: 10.1111/j.1742-4658.2009.06896.x. Epub 2008 Feb 7. FEBS J. 2009. PMID: 19220462 Free article. Review.

4

Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents.

Riccio G, Esposito G, Leoncini E, Contu R, Condorelli G, Chiariello M, Laccetti P, Hrelia S, D'Alessio G, De Lorenzo C. Riccio G, et al. FASEB J. 2009 Sep;23(9):3171-8. doi: 10.1096/fj.09-131383. Epub 2009 May 5. FASEB J. 2009. PMID: 19417081

5

A novel ErbB2 epitope targeted by human antitumor immunoagents.

Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C. Troise F, et al. FEBS J. 2011 Apr;278(7):1156-66. doi: 10.1111/j.1742-4658.2011.08041.x. Epub 2011 Mar 1. FEBS J. 2011. PMID: 21288302 Free article.

6

Effects of a human compact anti-ErbB2 antibody on prostate cancer.

Malara AE, Fedele C, Aloj L, Arra C, Laccetti P, D'Alessio G, De Lorenzo C. Malara AE, et al. Oncol Rep. 2012 Jul;28(1):297-302. doi: 10.3892/or.2012.1760. Epub 2012 Apr 10. Oncol Rep. 2012. PMID: 22505344

7

Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.

Fedele C, Riccio G, Malara AE, D'Alessio G, De Lorenzo C. Fedele C, et al. Breast Cancer Res Treat. 2012 Jul;134(2):595-602. doi: 10.1007/s10549-012-2103-8. Epub 2012 Jun 7. Breast Cancer Res Treat. 2012. PMID: 22674190

8

A new human antitumor immunoreagent specific for ErbB2.

De Lorenzo C, Palmer DB, Piccoli R, Ritter MA, D'Alessio G. De Lorenzo C, et al. Clin Cancer Res. 2002 Jun;8(6):1710-9. Clin Cancer Res. 2002. PMID: 12060608

9

A human, compact, fully functional anti-ErbB2 antibody as a novel antitumour agent.

De Lorenzo C, Tedesco A, Terrazzano G, Cozzolino R, Laccetti P, Piccoli R, D'Alessio G. De Lorenzo C, et al. Br J Cancer. 2004 Sep 13;91(6):1200-4. doi: 10.1038/sj.bjc.6602110. Br J Cancer. 2004. PMID: 15305184 Free PMC article.

10

Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.

Gelardi T, Damiano V, Rosa R, Bianco R, Cozzolino R, Tortora G, Laccetti P, D'Alessio G, De Lorenzo C. Gelardi T, et al. Br J Cancer. 2010 Feb 2;102(3):513-9. doi: 10.1038/sj.bjc.6605499. Epub 2010 Jan 5. Br J Cancer. 2010. PMID: 20051960 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters